GlaxoSmithKline



Ebit Changement Date
AbbVie USD 5.72B 69M 2025-06
Alcon AG USD 511M 13M 2025-03
Almirall EUR 43.02M 3.42M 2025-06
Amgen USD 2.26B 1.34B 2025-06
argenx SE USD 288.02M 149.08M 2025-06
AstraZeneca USD 3.51B 1.3B 2025-06
Bayer EUR -36000000 2.95B 2025-06
Biogen USD 816.6M 233.8M 2025-06
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Eli Lilly USD 7.02B 3.32B 2025-06
Fresenius EUR 560M 94M 2025-06
Fresenius Medical Care EUR 431M 15M 2025-06
Galapagos EUR -57027000 101.68M 2025-06
Genmab DKK 432M 900.27M 2025-06
Gilead Sciences USD 2.7B 189M 2025-06
GlaxoSmithKline GBP 2.07B 462M 2025-06
Glaxosmithkline GBP 1.83B 1.76B 2024-12
GRIFOLS EUR 331.94M 57.97M 2025-06
Hikma Pharmaceutical USD 317M 85M 2024-12
Lonza CHF 727M 193M 2024-12
Merck EUR 1.03B 26M 2025-06
Merck USD 6.36B 149M 2025-06
Novartis USD -9190000000 13.87B 2025-06
Novo Nordisk 34.08B 4.71B 2025-06
Orion EUR 104.6M 26.7M 2025-06
Pfizer USD 2.6B 3.33B 2025-06
Philips EUR 488M 134M 2025-06
Recordati EUR 143.93M 51.87M 2025-06
Regeneron Pharmaceuticals USD 1.52B 608.6M 2025-06
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 1.51B 1.39B 2025-06
Smith & Nephew USD 440M 138M 2025-06
UCB EUR 502M 168M 2024-12


GlaxoSmithKline - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.